Inhalation Sciences AB (publ) to repay its loan by end of August 2023
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Inhalation Sciences AB (publ) to repay its loan by end of August 2023

(Stockholm, Sweden, 23 August 2023) Inhalation Sciences AB will repay a 1.8 MSEK loan which was reported in the Q1 Report 2023. The loan will be repaid by the end of August 2023. The contractual due date for repayment is December 2023. The total amount including interest and setup fee is approx. 2.6 MSEK.

In the Q1 Report (31 May 2023) ISAB reported that on January 16th, 2023 it had activated 1.8 MSEK of its credit facility, due to be repaid in December 2023. ISAB will now in advance repay the loan by the end of August 2023. The total loan amount is approx. 2.6 MSEK, including interest and setup fee. By the advanced repayment, the company will save approximately 200 KSEK in interest costs.

CEO Manoush Masarrat: “The early repayment reflects our current cash balance that has been strengthened by a good inflow of awarded customer contracts and in addition with the recent completed share issue. We feel comfortable repaying this loan now instead of waiting until December due to a satisfactory cash position, as well as achieving a saving of 200 KSEK on the interest”.

Bifogade filer

Nyheter om Inhalation Sciences

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Inhalation Sciences

Senaste nytt